Eagle Capital Growth Fund, Inc.EE

Eagle Capital Growth Fund, Inc.

9.82USDR
−0.08−0.81%
At close at Mar 27, 18:58 GMT
USD
No trades
See on Supercharts

GRF fundamentals

Key facts

Market capitalization‪39.28 M‬USD
Founded1989
CEOLuke Edward Sims
About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.

Ownership
‪‪3.97 M‬‬
Free Float shares
‪‪3.41 M‬‬ (86.05%)
Closely held shares
‪‪553.53 K‬‬ (13.95%)
Free Float shares
‪‪3.41 M‬‬ (86.05%)
Closely held shares
‪‪553.53 K‬‬ (13.95%)
Capital structure
Market cap
‪‪39.28 M‬‬
Cash & equivalents
‪‪7.69 M‬‬
Enterprise value
‪‪31.59 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪39.28 M‬‬
Price to earning ratio (P/E)
7.09x
Price to sales ratio (P/S)
11.57x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
7.09x
Price to sales ratio (P/S)
11.57x
Valuation ratios
‪0.00‬
‪5.50‬
‪11.00‬
‪16.50‬
‪22.00‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪2.10‬
‪4.20‬
‪6.30‬
‪8.40‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪100%‬
‪210%‬
‪320%‬
‪430%‬
‪540%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪900.00 K‬‬
‪‪1.80 M‬‬
‪‪2.70 M‬‬
‪‪3.60 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
Op expenses
Op income
Int expenses
Non-op income/expenses
Pretax income
Taxes & Other
Net income
‪0.00‬
‪‪800.00 K‬‬
‪‪1.60 M‬‬
‪‪2.40 M‬‬
‪‪3.20 M‬‬
Revenue
Op expenses
Op income
Expenses & adjustments
Net income
‪0.00‬
‪‪800.00 K‬‬
‪‪1.60 M‬‬
‪‪2.40 M‬‬
‪‪3.20 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Investment and Related Activities
By country
Period: 2024
United States

Dividends

Dividend yield, history and sustainability

Dividend summary
48.70%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
6.87%
Last payment
0.68
Last ex-date
Nov 29, 2024
Dividend history
‪3.5%‬
‪5.2%‬
‪6.9%‬
‪8.6%‬
‪10.3%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Dividends per share (FY)
Dividend yield (FY) %